BioCardia BCDA
NASDAQ BCDA
$1.10 -0.01 (-0.90%)
At close: Sep 9, 2026 · 4:00 PM EDT

BioCardia (BCDA) Gross Margin (QoQ) (2012 - 2021)

Analysis

BioCardia (BCDA) Gross Margin (QoQ) (2012 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn
10 BioCardia 13.06 Mn 8.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Dec 31, 2020 0.00
Sep 30, 2020 0.00
Jun 30, 2020 1,053.00
Mar 31, 2020 668.00
Dec 31, 2019 -484.00
Sep 30, 2019 20,972.00
Jun 30, 2019 -17,302.00
Mar 31, 2019 6,355.00
Dec 31, 2018 1,714.00
Sep 30, 2018 -7,328.00
Jun 30, 2018 2,241.00
Mar 31, 2018 8,611.00
Dec 31, 2017 -5,192.00
Sep 30, 2017 6,817.00
Jun 30, 2017 -5,351.00
Mar 31, 2017 -511.00
Dec 31, 2016 4,489.00
Sep 30, 2016 -5,919.00